Popular press Archives - Page 7 of 16

The Whitney G Sampson Lecture: Expanding CXL From Keratoconus to Infectious Keratitis

Prof. Farhad Hafezi, Medical Director of the ELZA Institute in Zurich, Switzerland, had the honor of delivering the prestigious Whitney G Sampson lecture on Sunday, October 13th, 2019 at the annual conference of American Academy of Ophthalmology (AAO) in San Francisco, California.

Which is stronger? PRK or SMILE?

A lot has been said about SMILE, some of which has been about how, in theory, corneas treated with SMILE should be biomechanically stronger than LASIK-treated corneas (more of the stronger anterior stroma is left intact compared with physically cutting a flap there in LASIK and lifting it to perform ablation of the stroma underneath). But what about PRK? This is ablation of the anterior stroma after having just removed the epithelial cells above it, on the surface of the cornea. So the question remains: which is stronger? PRK or SMILE? The short answer is that PRK is stronger.

Why I’m a Frequent Flyer

I fly. A lot. To educate, to inform, to train scientists and surgeons in the latest advances in cross-linking. Yes, I worry about my carbon footprint. Yes, I miss my family when I’m gone. But it’s important that it’s done, and I explain in this blog post exactly why that’s true.

Cooling the cornea… for better cross-linking

EyeWorld’s Jonathan Kahn interviews Farhad Hafezi on a new method that might improve the efficacy of corneal cross-linking for the treatment of corneal ectasias like #keratoconus: cooling the cornea!

PACK-CXL: Cross-linking the cornea… to conquer infection

EyeWorld’s Jonathan Kahn (JK) interviews Farhad Hafezi (FH) for a PACK-CXL update.

Cross-Linking in thin corneas: simple, personal and more precise

Keratoconus is the progressive thinning of the cornea, and corneal cross-linking (CXL) can successfully treat it.

How long does the effect of cross-linking last?

Fifteen years into the clinical application of corneal cross-linking, we are collecting a growing number of long-term results from patients

Switzerland’s first Down Syndrome eye consultation

Keratoconus affects about 1 in 2,000 people in the general population, but 1 in 7 Down syndrome individuals are affected

Innovation in ophthalmology: how to protect new ideas

See this video interview with Nikki Hafezi on how to protect new ideas and innovations in ophthalmology.

ESCRS 2017 Highlights with Nikki Hafezi

Nikki Hafezi in a video interview with Touch Ophthalmology on the highlights of the ESCRS 2017 meeting in Lisbon.

Our Areas of Expertise

Laser Eye Surgery

Dry Eye

Myopia Control

Cornea

Cataract

Orbit

Keratoconus

Glaucoma

Eyelids

Cross-Linking

Retina

How to find us

Your first visit

Your surgery

International patients

Online video consultation

Downloads

Our Areas of Expertise

Laser Eye Surgery

Keratoconus

Cornea

Cataract

Eyelids

Glaucoma

Orbita

Cross-Linking

Dry Eye

Retina

ELZA Dietikon

ELZA HB Zürich

Request Callback

Email Us

Swiss patients:

Recommend Us

International Patients:

Popular Press

Our Areas of Expertise

Downloads

Our Areas of Expertise

ELZA Dietikon

ELZA HB Zürich

Popular Press

Newsletter

Thank you!

Newsletter

Vielen Dank!